This renewal of the University of Florida's Vision Research Core grant has two overarching aims: 1. To enhance the ability of Vision Research Core investigators in various departments at the University of Florida to perform studies in vision research using state-of-the-art techniques. Vision Research Core facilities support and enhance the existing, funded research programs of its members. Moreover, it is a resource for other vision research efforts across the campus, facilitates new initiatives and ensures that the latest technology and expertise is accessible to all vision researchers. 2. To promote collaborative and multidisciplinary studies in vision research. Collaboration, communication and interchange of ideas and expertise already exist to a high degree among our investigators and departments. The shared support facilities of the Vision Research Core serve to further solidify this sense of community, bolster common goals and objectives, and increase the level of interdisciplinary research on complex problems in the visual sciences.
These aims are accomplished through Vision Research Core service modules supported by this grant, by the Department of Ophthalmology, by the College of Medicine and by the University of Florida. We propose to meet the developing needs of the University of Florida vision researchers through four modules: 1) Cell & Tissue Culture/Immunology, 2) Molecular Genetics, 3) Structural Biology/Histology and 4) In-Life Ocular Analysis. Each module offers state-of-the art instruments, services and advice, and continues to evolve to best meet the changing needs of its users in this rapidly developing era of ocular research.
This group of NEI funded researchers with diverse expertise have, for the past 21 years, used the University of Florida's Vision Research Core services to help develop treatments for ocular maladies ranging from recessive, dominant and X-linked retinal degenerative diseases, to AMD and diabetic retinopathy to corneal scarring to Herpesviral ocular infections. This P30 support is critically important to that continued progress.
|Yang, Fan; Ma, Hongwei; Belcher, Joshua et al. (2016) Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration. FASEB J 30:4313-4325|
|Hickmott, Jack W; Chen, Chih-Yu; Arenillas, David J et al. (2016) PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina. Mol Ther Methods Clin Dev 3:16051|
|Tuli, Sonal; Gray, Matthew (2016) Surgical management of corneal infections. Curr Opin Ophthalmol 27:340-7|
|Boyd, R F; Boye, S L; Conlon, T J et al. (2016) Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs. Gene Ther 23:548-56|
|Berkowitz, Bruce A; Lewin, Alfred S; Biswal, Manas R et al. (2016) MRI of Retinal Free Radical Production With Laminar Resolution In Vivo. Invest Ophthalmol Vis Sci 57:577-85|
|Choudhury, Shreyasi; Strang, Christianne E; Alexander, John J et al. (2016) Novel Methodology for Creating Macaque Retinas with Sortable Photoreceptors and Ganglion Cells. Front Neurosci 10:551|
|Ildefonso, Cristhian J; Biswal, Manas R; Ahmed, Chulbul M et al. (2016) The NLRP3 Inflammasome and its Role in Age-Related Macular Degeneration. Adv Exp Med Biol 854:59-65|
|Boye, Sanford L; Bennett, Antonette; Scalabrino, Miranda L et al. (2016) Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors. J Virol 90:4215-31|
|Langlo, Christopher S; Patterson, Emily J; Higgins, Brian P et al. (2016) Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia. Invest Ophthalmol Vis Sci 57:3984-95|
|Akin, Debra; Newman, Jeremy R B; McIntyre, Lauren M et al. (2016) RNA-seq analysis of impact of PNN on gene expression and alternative splicing in corneal epithelial cells. Mol Vis 22:40-60|
Showing the most recent 10 out of 238 publications